Cargando…

A longitudinal study of emotional adjustment, quality of life and adaptive function in attenuated MPS II

OBJECTIVES: The behavioral, adaptive and quality of life characteristics of attenuated mucopolysaccharidosis type II (MPS II) have not been well studied. Understanding changes over time in the attenuated phenotype may assist in helping achieve better outcomes in long-term function. This longitudinal...

Descripción completa

Detalles Bibliográficos
Autores principales: Shapiro, Elsa G., Rudser, Kyle, Ahmed, Alia, Steiner, Robert D., Delaney, Kathleen A., Yund, Brianna, King, Kelly, Kunin-Batson, Alicia, Eisengart, Julie, Whitley, Chester B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4832084/
https://www.ncbi.nlm.nih.gov/pubmed/27114914
http://dx.doi.org/10.1016/j.ymgmr.2016.03.005
_version_ 1782427190073229312
author Shapiro, Elsa G.
Rudser, Kyle
Ahmed, Alia
Steiner, Robert D.
Delaney, Kathleen A.
Yund, Brianna
King, Kelly
Kunin-Batson, Alicia
Eisengart, Julie
Whitley, Chester B.
author_facet Shapiro, Elsa G.
Rudser, Kyle
Ahmed, Alia
Steiner, Robert D.
Delaney, Kathleen A.
Yund, Brianna
King, Kelly
Kunin-Batson, Alicia
Eisengart, Julie
Whitley, Chester B.
author_sort Shapiro, Elsa G.
collection PubMed
description OBJECTIVES: The behavioral, adaptive and quality of life characteristics of attenuated mucopolysaccharidosis type II (MPS II) have not been well studied. Understanding changes over time in the attenuated phenotype may assist in helping achieve better outcomes in long-term function. This longitudinal study investigates these outcomes in relation to age, somatic disease burden, and IQ. Specifically, somatic disease burden is a major challenge for these patients, even with treatment with enzyme replacement therapy. METHODS: 15 patients, 10 between ages 6 and < 12 and 5 between ages ≥ 12 and 18, were selected who had at least 2 yearly visits. The occurrence of physical signs, the Physical Symptom Score, and IQ in these two groups was studied as well as the longitudinal association of age with standardized measures of quality of life, adaptive function, and behavioral symptoms as rated by parents and the child's self-report. Slopes by age across and within patients were calculated for these measures. RESULTS: All but one child had hearing loss, most had joint contractures and short stature. Somatic disease burden increased with age. IQ, although normal for most, also improved with age in those under 12 years of age. Physical quality of life decreased while psychosocial quality of life increased with age. Although other adaptive skills were in the broad average range, daily living skills were low at baseline relative to normative data and decreased over time. Behavior ratings indicated improvement in attention and hyperactivity over time. No patient had severe psychopathology, but older children reported an increasing sense of inadequacy and low self-esteem on self-report, presumably due to increasing awareness of differences from peers over time. CONCLUSIONS: Attenuated MPS II patients have increasing somatic disease burden and poor physical quality of life as they develop as well as decreasing self-esteem and sense of adequacy. Psychosocial quality of life, adaptive skills, and attention improve. Recognition of and intervention around these issues will be beneficial to MPS II attenuated patients who have the resources to use such assistance to improve their long-term outcomes.
format Online
Article
Text
id pubmed-4832084
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-48320842016-04-25 A longitudinal study of emotional adjustment, quality of life and adaptive function in attenuated MPS II Shapiro, Elsa G. Rudser, Kyle Ahmed, Alia Steiner, Robert D. Delaney, Kathleen A. Yund, Brianna King, Kelly Kunin-Batson, Alicia Eisengart, Julie Whitley, Chester B. Mol Genet Metab Rep Research Paper OBJECTIVES: The behavioral, adaptive and quality of life characteristics of attenuated mucopolysaccharidosis type II (MPS II) have not been well studied. Understanding changes over time in the attenuated phenotype may assist in helping achieve better outcomes in long-term function. This longitudinal study investigates these outcomes in relation to age, somatic disease burden, and IQ. Specifically, somatic disease burden is a major challenge for these patients, even with treatment with enzyme replacement therapy. METHODS: 15 patients, 10 between ages 6 and < 12 and 5 between ages ≥ 12 and 18, were selected who had at least 2 yearly visits. The occurrence of physical signs, the Physical Symptom Score, and IQ in these two groups was studied as well as the longitudinal association of age with standardized measures of quality of life, adaptive function, and behavioral symptoms as rated by parents and the child's self-report. Slopes by age across and within patients were calculated for these measures. RESULTS: All but one child had hearing loss, most had joint contractures and short stature. Somatic disease burden increased with age. IQ, although normal for most, also improved with age in those under 12 years of age. Physical quality of life decreased while psychosocial quality of life increased with age. Although other adaptive skills were in the broad average range, daily living skills were low at baseline relative to normative data and decreased over time. Behavior ratings indicated improvement in attention and hyperactivity over time. No patient had severe psychopathology, but older children reported an increasing sense of inadequacy and low self-esteem on self-report, presumably due to increasing awareness of differences from peers over time. CONCLUSIONS: Attenuated MPS II patients have increasing somatic disease burden and poor physical quality of life as they develop as well as decreasing self-esteem and sense of adequacy. Psychosocial quality of life, adaptive skills, and attention improve. Recognition of and intervention around these issues will be beneficial to MPS II attenuated patients who have the resources to use such assistance to improve their long-term outcomes. Elsevier 2016-04-01 /pmc/articles/PMC4832084/ /pubmed/27114914 http://dx.doi.org/10.1016/j.ymgmr.2016.03.005 Text en © 2016 The Authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Research Paper
Shapiro, Elsa G.
Rudser, Kyle
Ahmed, Alia
Steiner, Robert D.
Delaney, Kathleen A.
Yund, Brianna
King, Kelly
Kunin-Batson, Alicia
Eisengart, Julie
Whitley, Chester B.
A longitudinal study of emotional adjustment, quality of life and adaptive function in attenuated MPS II
title A longitudinal study of emotional adjustment, quality of life and adaptive function in attenuated MPS II
title_full A longitudinal study of emotional adjustment, quality of life and adaptive function in attenuated MPS II
title_fullStr A longitudinal study of emotional adjustment, quality of life and adaptive function in attenuated MPS II
title_full_unstemmed A longitudinal study of emotional adjustment, quality of life and adaptive function in attenuated MPS II
title_short A longitudinal study of emotional adjustment, quality of life and adaptive function in attenuated MPS II
title_sort longitudinal study of emotional adjustment, quality of life and adaptive function in attenuated mps ii
topic Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4832084/
https://www.ncbi.nlm.nih.gov/pubmed/27114914
http://dx.doi.org/10.1016/j.ymgmr.2016.03.005
work_keys_str_mv AT shapiroelsag alongitudinalstudyofemotionaladjustmentqualityoflifeandadaptivefunctioninattenuatedmpsii
AT rudserkyle alongitudinalstudyofemotionaladjustmentqualityoflifeandadaptivefunctioninattenuatedmpsii
AT ahmedalia alongitudinalstudyofemotionaladjustmentqualityoflifeandadaptivefunctioninattenuatedmpsii
AT steinerrobertd alongitudinalstudyofemotionaladjustmentqualityoflifeandadaptivefunctioninattenuatedmpsii
AT delaneykathleena alongitudinalstudyofemotionaladjustmentqualityoflifeandadaptivefunctioninattenuatedmpsii
AT yundbrianna alongitudinalstudyofemotionaladjustmentqualityoflifeandadaptivefunctioninattenuatedmpsii
AT kingkelly alongitudinalstudyofemotionaladjustmentqualityoflifeandadaptivefunctioninattenuatedmpsii
AT kuninbatsonalicia alongitudinalstudyofemotionaladjustmentqualityoflifeandadaptivefunctioninattenuatedmpsii
AT eisengartjulie alongitudinalstudyofemotionaladjustmentqualityoflifeandadaptivefunctioninattenuatedmpsii
AT whitleychesterb alongitudinalstudyofemotionaladjustmentqualityoflifeandadaptivefunctioninattenuatedmpsii
AT shapiroelsag longitudinalstudyofemotionaladjustmentqualityoflifeandadaptivefunctioninattenuatedmpsii
AT rudserkyle longitudinalstudyofemotionaladjustmentqualityoflifeandadaptivefunctioninattenuatedmpsii
AT ahmedalia longitudinalstudyofemotionaladjustmentqualityoflifeandadaptivefunctioninattenuatedmpsii
AT steinerrobertd longitudinalstudyofemotionaladjustmentqualityoflifeandadaptivefunctioninattenuatedmpsii
AT delaneykathleena longitudinalstudyofemotionaladjustmentqualityoflifeandadaptivefunctioninattenuatedmpsii
AT yundbrianna longitudinalstudyofemotionaladjustmentqualityoflifeandadaptivefunctioninattenuatedmpsii
AT kingkelly longitudinalstudyofemotionaladjustmentqualityoflifeandadaptivefunctioninattenuatedmpsii
AT kuninbatsonalicia longitudinalstudyofemotionaladjustmentqualityoflifeandadaptivefunctioninattenuatedmpsii
AT eisengartjulie longitudinalstudyofemotionaladjustmentqualityoflifeandadaptivefunctioninattenuatedmpsii
AT whitleychesterb longitudinalstudyofemotionaladjustmentqualityoflifeandadaptivefunctioninattenuatedmpsii